Universitätsklinikum Tübingen

IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma (2026) Horns JM, Beder T, Künstner A, Barz MJ, Bendig S, Bozzetti C, Chitadze G, et al. Journal article Sex Differences in Pediatric and Adolescent Endocrinology: What Are the Origins? (2026) Binder G, Dunstheimer D, Gohlke B, Heger S, Reinehr T, Richter-Unruh A, Wölfle J, Wüsthof A Journal article, Review article Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling study. (2026) Becker B, Cordts I, Becker J, Günther R, Baumann M, Bernert G, Eisenkölbl A, et al. Journal article Stereotactic heart ablative radiotherapy (SHARP): a prospective multicentric phase II trial. (2026) Gaasch A, Marschner SN, Hoegen-Saßmannshausen P, Sandrini E, Hörner-Rieber J, Andratschke N, Balermpas P, et al. Journal article Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial (Nature Medicine, (2026), 10.1038/s41591-026-04455-x) (2026) Wermke M, Ochsenreither S, Jaeger D, Becker H, Bleckmann A, Bozorgmehr F, Chatterjee M, et al. Journal article, Erratum INTERACT-CMIL: Multi-Task Shared Learning and Inter-Task Consistency for Conjunctival Melanocytic Intraepithelial Lesion Grading (2026) Ikinci M, Toma L, Loeffler KU, Ussem L, Susskind D, Weller J, Yeganeh Y, et al. Conference contribution Exploring Benefits of and Barriers to Patient Involvement Through Digital Tools in Psycho-Oncology: Qualitative Study Within the Reduct Trial (2026) Schug C, Bäuerle A, Graf J, Heinen J, Krakowczyk JB, Borho A, Koller K, et al. Journal article Endovascular Treatment of Abdominal Arterial Bleeding Which Cases Require Nighttime Intervention? Endovaskuläre Versorgung abdomineller arterieller Blutungen - was gehört in den Nachtdienst (2026) Auer TA, Schmid A, Gebauer B Journal article, Review article German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025) S1-Handlungsempfehlung der Deutschen Gesellschaft für Nuklearmedizin zur Durchführung von Hirnperfusions-SPECT-Untersuchungen mit 99mTc-markierten Radiopharmaka (Stand 09/2025) (2026) Buchert R, Meyer PT, Albert NL, Barthel H, Boecker H, Bouter C, Brendel M, et al. Journal article MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial (2026) Wermke M, Ochsenreither S, Jaeger D, Becker H, Bleckmann A, Bozorgmehr F, Chatterjee M, et al. Journal article